The involvement of skilled biostatisticians and bioinformaticians is critical for the success of research in the basic and translational sciences. Research that is conducted to reduce the burdens caused by the racial disparities in cancer incidence is no exception. For this reason, a Biostatistics and Bioinformatics Shared Resource (BBSR) is an integral part of this Morehouse School of Medicine/Tuskegee University and the University of Alabama at Birmingham Comprehensive Cancer Center Partnership. For full/pilot projects, outreach, research education and planning and evaluation activities, the BBSR provides consultation and collaborative support regarding study design, data management, and statistical and bioinformatics analyses. The BBSR also assists in the development of grant proposals, abstracts, and manuscripts. In addition to its work supporting the research of Partnership investigators, the BBSR's support enhances the biostatistical and bioinformatics capabilities of the Partnership institutions. This is accomplished by providing guidance to junior investigators and scholars (underrepresented undergraduate/graduate and medical students, medical residents, post-doctoral fellows, and junior faculty) regarding sound applications of statistics and bioinformatics principles in cancer research. The BBSR also participates in the Cancer Eeducation Programs of the Partnership.

Public Health Relevance

The Biostatistics and Bioinformatics Shared Resource of the Morehouse School of Medicine, Tuskegee University, and University of Alabama at Birmingham Comprehensive Cancer Center Partnership provides the statistical and bioinformatics needs of all research projects and cores, and educational opportunities for the research education program.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA118638-15
Application #
10007643
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2005-09-30
Project End
2021-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
15
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Morehouse School of Medicine
Department
Type
DUNS #
102005451
City
Atlanta
State
GA
Country
United States
Zip Code
30310
Ward, Ashley B; Mir, Hina; Kapur, Neeraj et al. (2018) Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol 16:108
Singh, Santosh Kumar; Mishra, Manoj K; Eltoum, Isam-Eldin A et al. (2018) CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells. Sci Rep 8:1323
Puri, Pawan; Schaefer, Caitlin M; Bushnell, Daniel et al. (2018) Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease. Am J Pathol 188:84-94
Nguyen, Thu-Cuc; Bajwa, Ravneet; Bari, Shahla et al. (2018) Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer. Oxf Med Case Reports 2018:omx078
Akinyemiju, Tomi; Moore, Justin Xavier; Pisu, Maria et al. (2018) A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality. Obesity (Silver Spring) 26:193-201
Chowdhury, Indrajit; Banerjee, Saswati; Driss, Adel et al. (2018) Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF-?B signaling pathway. J Cell Physiol :
Akintobi, Tabia Henry; Lockamy, Elise; Goodin, Lisa et al. (2018) Processes and Outcomes of a Community-Based Participatory Research-Driven Health Needs Assessment: A Tool for Moving Health Disparity Reporting to Evidence-Based Action. Prog Community Health Partnersh 12:139-147
Luo, Yanzhuo; Li, Bingjin; Zhang, Guangxin et al. (2018) Integrated Oncogenomic Profiling of Copy Numbers and Gene Expression in Lung Adenocarcinomas without EGFR Mutations or ALK Fusion. J Cancer 9:1096-1105
Sims, Alexis; Archie-Booker, Elaine; Waldrop, Reinetta T et al. (2018) Factors Associated with Human Papillomavirus Vaccination among Women in the United States. ARC J Public Health Community Med 3:6-12
Davis, Melissa; Tripathi, Shweta; Hughley, Raymond et al. (2018) AR negative triple negative or ""quadruple negative"" breast cancers in African American women have an enriched basal and immune signature. PLoS One 13:e0196909

Showing the most recent 10 out of 114 publications